Centre for Policy on Ageing
 

 
Cholinesterase inhibitor therapy for Alzheimer's disease and related dementias
Author(s)Howard Feldman
Journal titleInternational Psychogeriatrics, vol 14, supplement 1, 2002
Pages126 pp (whole issue)
KeywordsDementia ; Drugs ; Clinical surveys ; Research Reviews.
AnnotationIn the last five years, cholinesterase (ChE) inhibitors have passed efficacy and safety tests for the management of Alzheimer's disease (AD) and related dementias. This supplement of International Psychogeriatrics comprises clinical reviews of ChE inhibitors, focusing on donepezil, galantamine and rivastigmine. (RH).
Accession NumberCPA-030425201 A
ClassmarkEA: LLD: 3G: 3A:6KC

Data © Centre for Policy on Ageing
...from the Ageinfo database published by Centre for Policy on Ageing.
 
CPA home >> Ageinfo Database >> Last modified: Fri 21 Sep 2018, © CPA 2018 Queries to: webmaster@cpa.org.uk